• About us
• Contact

Advertisement

Organisation › Details

Cambridge Research Biochemicals Ltd. (CRB)

Cambridge Research Biochemicals (www.crbdiscovery.com) is a leading independent producer of custom-made peptide and antibody tools, supplying researchers in the pharmaceutical, life science and academic sectors worldwide. The primary applications of its products are as custom-made, laboratory scale reagents for proof of principal studies within early phase drug discovery and to support biomarker programmes in clinical studies. The company produces all flavours of peptides from simple to modified, stable and radio-labelled to dye labelled from milligrams to gram-scale to the highest levels of purity. In addition, CRB is a recognised expert at generating highly specific and targeted antibodies (both polyclonal and monoclonal). Fluorescent dye labelling is also a focus. *

 

	Start	1980-01-01 established pred
	End	2023-06-09 renamed
	Group	Biosynth (since 9/22) (Group)
	Today	Biosynth Laboratories Ltd.
	Successor	Biosynth Laboratories Ltd.
	Industry	peptide service
	Industry 2	peptide synthesis
	Region	Billingham, Durham
	Country	United Kingdom (GB)
	Street	17-19 Belasis Court Belasis Hall Technology Park
	City	TS23 4AZ Billingham, Cleveland
	Tel	+44-1642-567180
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
		* Document for »About Section«: Biosynth AG. (5/9/23). "Press Release: Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge Research Biochemicals". Staad.
		Record changed: 2025-03-16

Advertisement

More documents for Biosynth (since 9/22) (Group)

• [1] Biosynth AG. (9/25/23). "Press Release: Biosynth Extends its Offering to Multi-Kilogram GMP Peptide Synthesis through the Acquisition of Pepceuticals". Staad....
• [2] Biosynth AG. (7/11/23). "Press Release: Biosynth Expands Capabilities with Acquisition of Celares, Experts in Bioconjugation and Specialty Polymers". Staad....
• [3] Biosynth AG. (5/9/23). "Press Release: Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge Research Biochemicals". Staad....
• [4] Biosynth AG. (1/19/23). "Press Release: Biosynth Hit 1M Products in Catalog. The Widest Catalog to Be the Leading Global Supplier"....
• [5] Biosynth AG. (9/7/22). "Press Release: Biosynth Carbosynth, Vivitide and Pepscan Rebrand to Biosynth". Staad....
• [6] Biosynth Carbosynth. (8/2/22). "Press Release: Biosynth Carbosynth to Offer Enzyme Development Following Acquisition of Eucodis Bioscience". Staad....
• [7] Biosynth Carbosynth. (6/30/22). "Press Release: Biosynth Carbosynth Expands Peptide Offering with Acquisition of Pepscan". Staad....
• [8] Biosynth Carbosynth. (5/25/22). "Press Release: Biosynth Carbosynth Further Expands Life Sciences Platform with Acquisition of Aalto Bio Reagents". Staad....
• [9] Bicycle Therapeutics plc. (11/20/20). "Press Release: Bicycle Therapeutics Announces Settlement of Patent Dispute with Pepscan Systems B.V.". Cambridge & Boston, MA....
• [10] Biosynth Carbosynth. (11/3/20). "Press Release: Biosynth Carbosynth Expands Its Enzyme Offerings with Products for Industrial Applications"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.